PSMD2 and lung adenocarcinoma: In light of the PrognoScan database, Kaplan-Meier curves, and multivariate Cox analysis, our results confirmed that high expression of PSMD2 is correlated with poor prognosis and PSMD2 is an independent prognostic biomarker for overall survival of lung adenocarcinoma patients.